TilrayTLRY
About: Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Employees: 2,650
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
27% more repeat investments, than reductions
Existing positions increased: 99 | Existing positions reduced: 78
0% less funds holding
Funds holding: 353 [Q1] → 352 (-1) [Q2]
2% less first-time investments, than exits
New positions opened: 47 | Existing positions closed: 48
9% less call options, than puts
Call options by funds: $16.9M | Put options by funds: $18.5M
1.94% less ownership
Funds ownership: 11.88% [Q1] → 9.94% (-1.94%) [Q2]
37% less capital invested
Capital invested by funds: $218M [Q1] → $137M (-$81.1M) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Roth MKM Bill Kirk 61% 1-year accuracy 11 / 18 met price target | 10%upside $1.75 | Neutral Maintained | 11 Oct 2024 |
Financial journalist opinion
Based on 30 articles about TLRY published over the past 30 days
